Loading...
Loading...
Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp.. Spoken Alpha tracks BIOX's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks BIOX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BIOX.
curl https://api.spokenalpha.com/v1/companies/BIOX| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.35 | $4.15 | -19.3% | -0.1% | +2.4% |
| Q4 FY2026 | $3.31 | $4.31 | -23.3% | +3.1% | +0.9% |
| Q3 FY2026 | $3.09 | $4.21 | -26.5% | +0.9% | +2.6% |
| Q2 FY2026 | $3.25 | $4.23 | -23.2% | +6.8% | +6.4% |
| Q1 FY2025 | $3.32 | $4.38 | -24.2% | -4.5% | -7.3% |
| Q4 FY2025 | $3.70 | $4.52 | -18.1% | -1.5% | -4.1% |
| Q3 FY2025 | $3.19 | $4.39 | -27.3% | +6.7% | +8.7% |
| Q2 FY2025 | $3.62 | $4.56 | -20.7% | -0.7% | 0.0% |
| Q1 FY2024 | $3.17 | $4.57 | -30.6% | -0.5% | -1.9% |
| Q4 FY2024 | $3.25 | $4.38 | -25.7% | +4.2% | +2.1% |